Apex Neuro-Scan Research And Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 12-12-2024
- Paid Up Capital ₹ 4.82 M
as on 12-12-2024
- Company Age 25 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.13 Cr
as on 12-12-2024
- Satisfied Charges ₹ 1.20 Cr
as on 12-12-2024
- Revenue -5.76%
(FY 2020)
- Profit 27.17%
(FY 2020)
- Ebitda -14.04%
(FY 2020)
- Net Worth -20.34%
(FY 2020)
- Total Assets -15.67%
(FY 2020)
About Apex Neuro-Scan Research And Diagnostic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.82 M.
The company currently has active open charges totaling ₹4.13 Cr. The company has closed loans amounting to ₹1.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Naresh Santuka and Jai Sharma serve as directors at the Company.
- CIN/LLPIN
U85195OR1999PTC005863
- Company No.
005863
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Cuttack, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Apex Neuro-Scan Research And Diagnostic?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Santuka  | Managing Director | 01-Feb-2001 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jai Sharma | Director | 02-Aug-1999 | Current |
Financial Performance of Apex Neuro-Scan Research And Diagnostic.
Apex Neuro-Scan Research And Diagnostic Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 5.76% decrease. The company also saw a substantial improvement in profitability, with a 27.17% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apex Neuro-Scan Research And Diagnostic?
In 2019, Apex Neuro-Scan Research And Diagnostic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Apr 2017 | ₹4.13 Cr | Open |
Orissa State Financaial Creation Date: 13 Mar 2000 | ₹1.20 Cr | Satisfied |
How Many Employees Work at Apex Neuro-Scan Research And Diagnostic?
Apex Neuro-Scan Research And Diagnostic has a workforce of 26 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apex Neuro-Scan Research And Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Neuro-Scan Research And Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
